3689.HK

Guangdong Kanghua Healthcare Co., Ltd. [3689.HK] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

3689.HK Stock Summary

Earnings are expected to fall -100% next year

3689.HK has less than 1 year of cash runway

In the News

3689.HK Financial details

Company Rating

Buy

Market Cap

698.88M

Income

115.84M

Revenue

1.97B

Book val./share

4.62

Cash/share

2.08

Dividend

Dividend %

Employees

3.95K

Optionable

Shortable

Yes

Earnings

29 Mar 2024

P/E

23.53

Forward P/E

PEG

3.22

P/S

0.38

P/B

0.44

P/C

1.01

P/FCF

6.52

Quick Ratio

0.9

Current Ratio

1.35

Debt / Equity

0.27

LT Debt / Equity

0.23

EPS (TTM)

0.35

EPS next Y

EPS next Q

EPS this Y

-58.55%

EPS next Y

EPS next 5Y

EPS last 5Y

-30.19%

Revenue last 5Y

2.4%

Revenue Q/Q

EPS Q/Q

SMA20

SMA50

SMA100

Inst Own

Inst Trans

ROA

ROE

ROC

0.04%

Gross Margin

14%

Oper. Margin

Profit Margin

Payout

Shs Outstand

Shs Float

Target Price

52W Range

1.04-2.4

52W High

+5%

52W Low

+110%

RSI

Rel Volume

2.94

Avg Volume

3.47K

Volume

10.2K

Perf Week

-2.78%

Perf Month

-4.55%

Perf Quarter

Perf Half Y

7.69%

Beta

0.531

Volatility

0.02%, 0.12%

Prev Close

Price

2.1

Change

3689.HK Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	4.9	5.85	5.23	5.84	5.52
Net income per share	0.5	0.15	-0.15	0.2	0.08
Operating cash flow per share	0.53	0.29	0.82	1	0.66
Free cash flow per share	0.26	-0.36	0.08	0.49	0.32
Cash per share	2.04	2.1	1.75	2.3	2.26
Book value per share	4.12	4.06	3.99	4.27	4.45
Tangible book value per share	3.97	3.99	4.08	4.32	4.41
Share holders equity per share	4.12	4.06	3.99	4.27	4.45
Interest debt per share	0	1.37	1.46	1.54	1.33
Market cap	1.89B	1.39B	898.97M	786M	531.55M
Enterprise value	1.68B	1.6B	1.19B	1.04B	697.13M
P/E ratio	11.23	28.45	-17.96	11.74	19.16
Price to sales ratio	1.15	0.71	0.52	0.4	0.29
POCF ratio	10.66	14.11	3.27	2.36	2.4
PFCF ratio	21.78	-11.47	32.39	4.85	5
P/B Ratio	1.37	1.02	0.67	0.55	0.36
PTB ratio	1.37	1.02	0.67	0.55	0.36
EV to sales	1.03	0.82	0.68	0.53	0.38
Enterprise value over EBITDA	6.24	6.79	9.82	3.61	3.13
EV to operating cash flow	9.51	16.34	4.3	3.13	3.15
EV to free cash flow	19.43	-13.28	42.7	6.43	6.56
Earnings yield	0.09	0.04	-0.06	0.09	0.05
Free cash flow yield	0.05	-0.09	0.03	0.21	0.2
Debt to equity	0	0.33	0.35	0.35	0.29
Debt to assets	0	0.17	0.19	0.18	0.16
Net debt to EBITDA	-0.75	0.92	2.37	0.89	0.74
Current ratio	1.42	1.54	1.49	1.45	1.35
Interest coverage	183.45	6.6	-1.01	7.05	4.86
Income quality	0.8	0.84	-10.55	2.58	3.19
Dividend Yield	0.03	0.04	0	0	0
Payout ratio	0.32	1.1	0	0	0
Sales general and administrative to revenue	0.11	0.12	0.13	0.12	0.12
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.08	0.05	0.02	0.01	0.01
Capex to operating cash flow	-0.51	-2.23	-0.9	-0.51	-0.52
Capex to revenue	-0.06	-0.11	-0.14	-0.09	-0.06
Capex to depreciation	-1.26	-1.79	-1.73	-1.15	-0.77
Stock based compensation to revenue	0	0	0	0	0
Graham number	6.83	3.65	3.67	4.38	2.88
ROIC	0.09	0.02	-0.02	0.03	0.01
Return on tangible assets	0.08	0.02	-0.02	0.03	0.01
Graham Net	0.03	-0.57	-0.84	-0.74	-0.74
Working capital	286.03M	378.18M	294.4M	347.43M	289.56M
Tangible asset value	1.33B	1.34B	1.36B	1.45B	1.47B
Net current asset value	265.54M	-51.87M	-155.11M	-105.09M	-92.28M
Invested capital	0	0.33	0.35	0.35	0.29
Average receivables	0	132.08M	234.43M	215.59M	228.05M
Average payables	269.77M	262.98M	259.42M	289.22M	335.23M
Average inventory	44.94M	57.56M	63.26M	70.35M	85.34M
Days sales outstanding	0	49.31	42.82	42.31	45.41
Days payables outstanding	75.24	61.07	63.25	73.32	80.36
Days of inventory on hand	12.93	16.26	13.98	19.13	19.99
Receivables turnover	0	7.4	8.52	8.63	8.04
Payables turnover	4.85	5.98	5.77	4.98	4.54
Inventory turnover	28.23	22.45	26.11	19.08	18.26
ROE	0.12	0.04	-0.04	0.05	0.02
Capex per share	-0.27	-0.65	-0.74	-0.51	-0.34

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric	2022-06-30	2022-09-30	2022-12-31	2023-03-31	2023-06-30
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	1.29	1.47	1.47	1.47	1.47
Net income per share	-0.01	0.1	0.1	0.08	0.08
Operating cash flow per share	0.08	0.26	0.26	0.09	0.09
Free cash flow per share	0.01	0.15	0.15	-0.03	-0.03
Cash per share	2.22	2.26	2.26	1.03	2.08
Book value per share	4.25	4.45	4.45	4.62	4.62
Tangible book value per share	4.26	4.41	4.41	4.52	4.52
Share holders equity per share	4.25	4.45	4.45	4.62	4.62
Interest debt per share	1.38	0.75	1.31	0.79	1.29
Market cap	542.33M	554.63M	531.55M	645.21M	496.01M
Enterprise value	882.77M	290.29M	697.13M	360.2M	636.6M
P/E ratio	-56.84	4.25	4.08	6.37	4.9
Price to sales ratio	1.26	1.13	1.08	1.31	1
POCF ratio	21.51	6.49	6.22	20.62	15.85
PFCF ratio	159.25	11.16	10.7	-65.18	-50.11
P/B Ratio	0.38	0.37	0.36	0.42	0.32
PTB ratio	0.38	0.37	0.36	0.42	0.32
EV to sales	2.05	0.59	1.42	0.73	1.29
Enterprise value over EBITDA	64.91	5.05	12.12	7.35	12.99
EV to operating cash flow	35.02	3.4	8.15	11.51	20.35
EV to free cash flow	259.22	5.84	14.03	-36.39	-64.31
Earnings yield	0	0.06	0.06	0.04	0.05
Free cash flow yield	0.01	0.09	0.09	-0.02	-0.02
Debt to equity	0.33	0.17	0.29	0.17	0.27
Debt to assets	0.17	0.09	0.16	0.1	0.16
Net debt to EBITDA	25.03	-4.6	2.88	-5.82	2.87
Current ratio	1.35	1.35	1.35	1.52	1.52
Interest coverage	0	0	4.05	0	3
Income quality	-10.57	2.62	2.62	1.24	1.24
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0.13	0.01	0.01	0.13	0.13
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.01	0.01	0.01	0.01	0.01
Capex to operating cash flow	-0.86	-0.42	-0.42	-1.32	-1.32
Capex to revenue	-0.05	-0.07	-0.07	-0.08	-0.08
Capex to depreciation	-0.58	-0.96	-0.96	-1.13	-1.13
Stock based compensation to revenue	0	0	0	0	0
Graham number	0.83	3.12	3.12	2.8	2.8
ROIC	-0.02	0.01	0.01	0.01	0.01
Return on tangible assets	0	0.01	0.01	0.01	0.01
Graham Net	-0.83	-0.74	-0.74	-1.55	-0.51
Working capital	287.4M	289.56M	289.56M	392.58M	392.58M
Tangible asset value	1.42B	1.47B	1.47B	1.51B	1.51B
Net current asset value	-130.58M	-92.28M	-92.28M	31.24M	31.24M
Invested capital	0.33	0.17	0.29	0.17	0.27
Average receivables	0	243.21M	229.62M	254.64M	279.67M
Average payables	0	302.83M	348.81M	331.4M	313.99M
Average inventory	0	74.77M	86.75M	81.56M	76.38M
Days sales outstanding	53.58	42.05	42.05	50.98	50.98
Days payables outstanding	59.72	75.99	75.99	69.22	69.22
Days of inventory on hand	14.6	18.9	18.9	16.84	16.84
Receivables turnover	1.68	2.14	2.14	1.77	1.77
Payables turnover	1.51	1.18	1.18	1.3	1.3
Inventory turnover	6.16	4.76	4.76	5.35	5.35
ROE	0	0.02	0.02	0.02	0.02
Capex per share	-0.07	-0.11	-0.11	-0.12	-0.12

3689.HK Frequently Asked Questions

What is Guangdong Kanghua Healthcare Co., Ltd. stock symbol ?

Guangdong Kanghua Healthcare Co., Ltd. is a CN stock and trading under the symbol 3689.HK

What is Guangdong Kanghua Healthcare Co., Ltd. stock quote today ?

Guangdong Kanghua Healthcare Co., Ltd. stock price is $2.1 today.

Is Guangdong Kanghua Healthcare Co., Ltd. stock public?

Yes, Guangdong Kanghua Healthcare Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Same Price Range

Similar Market Cap

Company Profile

Volume Average 3.47K
Market Capitalization 698.88M
Employee 3.95K
CEO Mr. Wangzhi Chen
Headquarters Dongguan,CN
IPO Date 2016-11-08
Website https://www.kanghuagp.com/tc/Home.aspx

Guangdong Kanghua Healthcare Co., Ltd., an investment holding company, primarily operates private hospitals in the People's Republic of China. The company operates through Hospital Services, Rehabilitation and Other Healthcare Services, Sale of Pharmaceutical Products, and Elderly Healthcare Services segments. It provides inpatient and outpatient healthcare, and physical examination services. The company also offers VIP inpatient and outpatient services; assisted reproductive services for couples with infertility disorders; surgical and non-surgical cosmetic treatment options; and laser treatment and skin care services, including acne, acne scarring, stretch marks, and pigmentation treatment, as well as laser hair removal services. In addition, it provides rehabilitation services to patients with physical or mental disabilities; and other healthcare-related services, including elderly care and training service for the disabled, as well as sells pharmaceutical products and medical consumables. Further, the company offers elderly healthcare services, including assisted living, adult daycare, long-term care, residential care, and hospice care to the aged patients. It operates Kanghua Hospital, Renkang Hospital, and Kangxin Hospital. The company was formerly known as Dongguan Kanghua Enterprise Co., Ltd. and changed its name to Guangdong Kanghua Healthcare Co., Ltd. in December 2015. The company was incorporated in 2002 and is headquartered in Dongguan, the People's Republic of China. Guangdong Kanghua Healthcare Co., Ltd. is a subsidiary of Dongguan Kanghua Investment Group Co., Ltd.